{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:32:30Z","timestamp":1787740350976,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12282-021-01260-x","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T05:04:19Z","timestamp":1620709459000},"page":"1243-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-5586","authenticated-orcid":false,"given":"Antonia","family":"Pearson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda E.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"issue":"1","key":"1260_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-015-3434-z","volume":"152","author":"S Mazzarello","year":"2015","unstructured":"Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, Ng T, Clemons M. Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat. 2015;152(1):1\u20138. https:\/\/doi.org\/10.1007\/s10549-015-3434-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1260_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0193945910391483","volume":"34","author":"J Lester","year":"2012","unstructured":"Lester J, Bernhard L, Ryan-Wenger N. A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res. 2012;34(1):72\u201396. https:\/\/doi.org\/10.1177\/0193945910391483.","journal-title":"West J Nurs Res"},{"issue":"8","key":"1260_CR3","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1200\/jco.1999.17.8.2365","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17(8):2365\u201370. https:\/\/doi.org\/10.1200\/jco.1999.17.8.2365.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1260_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jpm5020050","volume":"5","author":"J Lester","year":"2015","unstructured":"Lester J, Pahouja G, Andersen B, Lustberg M. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med. 2015;5(2):50\u201366. https:\/\/doi.org\/10.3390\/jpm5020050.","journal-title":"J Pers Med"},{"issue":"21","key":"1260_CR5","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/jco.2004.08.029","volume":"22","author":"L Fallowfield","year":"2004","unstructured":"Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol. 2004;22(21):4261\u201371. https:\/\/doi.org\/10.1200\/jco.2004.08.029.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1260_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/gme.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063\u20138. https:\/\/doi.org\/10.1097\/gme.0000000000000329.","journal-title":"Menopause"},{"issue":"2","key":"1260_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/13697137.2014.975197","volume":"18","author":"S Salvatore","year":"2015","unstructured":"Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Maggiore ULR. Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy. Climacteric. 2015;18(2):219\u201325. https:\/\/doi.org\/10.3109\/13697137.2014.975197.","journal-title":"Climacteric"},{"issue":"6","key":"1260_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","volume":"15","author":"N Biglia","year":"2015","unstructured":"Biglia N, Bounous VE, Sgro LG, D\u2019Alonzo M, Pecchio S, Nappi RE. Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes? Clin Breast Cancer. 2015;15(6):413\u201320. https:\/\/doi.org\/10.1016\/j.clbc.2015.06.005.","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"1260_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/713605341","volume":"6","author":"JE Dew","year":"2003","unstructured":"Dew JE, Wren BG, Eden JA. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric. 2003;6(1):45\u201352. https:\/\/doi.org\/10.1080\/713605341.","journal-title":"Climacteric"},{"issue":"10","key":"1260_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","volume":"93","author":"ES O\u2019Meara","year":"2001","unstructured":"O\u2019Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst. 2001;93(10):754\u201362. https:\/\/doi.org\/10.1093\/jnci\/93.10.754.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1260_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","volume":"135","author":"I Le Ray","year":"2012","unstructured":"Le Ray I, Dell\u2019Aniello S, Bonnetain F, Azoulay L, Suissa S. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study. Breast Cancer Res Treat. 2012;135(2):603\u20139. https:\/\/doi.org\/10.1007\/s10549-012-2198-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1260_CR12","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1097\/aog.0000000000001351","volume":"127","author":"R Farrell","year":"2016","unstructured":"ACOG Committee, Farrell R. ACOG Committee opinion no. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127(3):e93-96. https:\/\/doi.org\/10.1097\/aog.0000000000001351.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1260_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/GME.0000000000001121","volume":"25","author":"SS Faubion","year":"2018","unstructured":"Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women\u2019s Sexual Health. Menopause. 2018;25(6):596\u2013608. https:\/\/doi.org\/10.1097\/GME.0000000000001121.","journal-title":"Menopause"},{"key":"1260_CR14","volume-title":"Management of menopausal symptoms in women who have received breast cancer treatment: systematic review","author":"Cancer Australia","year":"2016","unstructured":"Cancer Australia. Management of menopausal symptoms in women who have received breast cancer treatment: systematic review. Surry Hills: Cancer Australia; 2016."},{"issue":"2","key":"1260_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"1260_CR16","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"1260_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/GME.0000000000001194","volume":"26","author":"SA Kingsberg","year":"2019","unstructured":"Kingsberg SA, Larkin L, Krychman M, Parish SJ, Bernick B, Mirkin S. WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history. Menopause. 2019;26(2):124\u201331. https:\/\/doi.org\/10.1097\/GME.0000000000001194.","journal-title":"Menopause"},{"issue":"8","key":"1260_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","volume":"17","author":"N Biglia","year":"2017","unstructured":"Biglia N, Bounous VE, D\u2019Alonzo M, Ottino L, Tuninetti V, Robba E, Perrone T. Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer. 2017;17(8):611\u20137. https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008.","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"1260_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/gme.0000000000001311","volume":"26","author":"LA Richter","year":"2019","unstructured":"Richter LA, Han J, Bradley S, Lynce FC, Willey SC, Tefera E, Pollack CE. Topical estrogen prescribing patterns for urogenital atrophy among women with breast cancer: results of a national provider survey. Menopause. 2019;26(7):714\u20139. https:\/\/doi.org\/10.1097\/gme.0000000000001311.","journal-title":"Menopause"},{"issue":"2","key":"1260_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C, Flynn C, Dranitsaris G, Bolivar R, Clemons M. Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer. 2009;9(2):108\u201317. https:\/\/doi.org\/10.3816\/CBC.2009.n.020.","journal-title":"Clin Breast Cancer"},{"key":"1260_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31709-X","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019. https:\/\/doi.org\/10.1016\/S0140-6736(19)31709-X.","journal-title":"Lancet"},{"issue":"6","key":"1260_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/gme.0000000000001284","volume":"26","author":"SN Bhupathiraju","year":"2018","unstructured":"Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Crandall CJ, Shifren JL, Manson JE. Vaginal estrogen use and chronic disease risk in the nurses\u2019 health study. Menopause. 2018;26(6):603\u201310. https:\/\/doi.org\/10.1097\/gme.0000000000001284.","journal-title":"Menopause"},{"issue":"1","key":"1260_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/gme.0000000000000956","volume":"25","author":"CJ Crandall","year":"2018","unstructured":"Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA, Manson JE. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the women\u2019s health initiative observational study. Menopause. 2018;25(1):11\u201320. https:\/\/doi.org\/10.1097\/gme.0000000000000956.","journal-title":"Menopause"},{"issue":"2","key":"1260_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10549-014-2930-x","volume":"145","author":"G Donders","year":"2014","unstructured":"Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(\u00ae)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Res Treat. 2014;145(2):371\u20139. https:\/\/doi.org\/10.1007\/s10549-014-2930-x.","journal-title":"Breast Cancer Res Treat"},{"key":"1260_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/15387445.SABCS17-P3-12-01","author":"P Sanchez-Rovira","year":"2017","unstructured":"Sanchez-Rovira P, Hirschberg AL, Gil-Gil M, Antolin-Novoa S, Garcia-Estevez L, De Las Heras BB, Presa-Lorite J, Sanchez-Vigil De La Villa I, Suarez-Almarza J, Nieto-Magro C. 0.005% estriol vaginal gel in hormone receptor-positive postmenopausal women with early stage breast cancer in treatment with aromatase inhibitors (AIs) in the adjuvant setting. A phase II prospective, randomized, double-blind placebo-controlled study\u2014\"the Blissafe study\". Cancer Res. 2017. https:\/\/doi.org\/10.1158\/15387445.SABCS17-P3-12-01.","journal-title":"Cancer Res"},{"issue":"3","key":"1260_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","volume":"3","author":"ME Melisko","year":"2017","unstructured":"Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS. Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer a randomized clinical trial. JAMA Oncol. 2017;3(3):313\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3904.","journal-title":"JAMA Oncol"},{"key":"1260_CR27","volume-title":"NAMS responds to European medicines agency statement on vaginal creams","author":"SS Faubion","year":"2019","unstructured":"Faubion SS. NAMS responds to European medicines agency statement on vaginal creams. The North American Menopause Society; 2019."},{"issue":"3","key":"1260_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jsxm.2017.01.010","volume":"14","author":"SA Kingsberg","year":"2017","unstructured":"Kingsberg SA, Krychman M, Graham S, Bernick B, Mirkin S. The women\u2019s EMPOWER survey: identifying women\u2019s perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med. 2017;14(3):413\u201324. https:\/\/doi.org\/10.1016\/j.jsxm.2017.01.010.","journal-title":"J Sex Med"},{"issue":"1","key":"1260_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/gme.0000000000000955","volume":"25","author":"VL Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(1):21\u20138. https:\/\/doi.org\/10.1097\/gme.0000000000000955.","journal-title":"Menopause"},{"issue":"6","key":"1260_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/gme.0000000000001053","volume":"25","author":"T Pagano","year":"2018","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, Giuliano M, Lauria R, De Santo I, Conforti A, Gallo A, Nazzaro G, De Placido S, Locci M, De Placido G. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause. 2018;25(6):657\u201362. https:\/\/doi.org\/10.1097\/gme.0000000000001053.","journal-title":"Menopause"},{"key":"1260_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05384-9","author":"A Pearson","year":"2019","unstructured":"Pearson A, Booker A, Tio M, Marx G. Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Res Treat. 2019. https:\/\/doi.org\/10.1007\/s10549-019-05384-9.","journal-title":"Breast Cancer Res Treat"},{"key":"1260_CR32","unstructured":"FDA (2018) FDA warns against use of energy-based devices to perform vaginal \u2018rejuvenation\u2019 or vaginal cosmetic procedures: FDA safety communication. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic. Accessed 26 Aug 2020"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-021-01260-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:30:12Z","timestamp":1634157012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-021-01260-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s12282-021-01260-x","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Belinda Kiely is on the advisory board and has received speaker honorarium and conference support from Roche, as well as advisory board and speaker honorarium from Novartis. Haryana Dhillon has received an honorarium from MSD paid to her institution. Antonia Pearson has received conference support from Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}